The legal prowess of Arnold & Porter Kaye Scholer LLP continues to leave a significant mark in the field of Intellectual Property (IP) law. The powerhouse firm has secured a victory for both Sanofi and Regeneron at the U.S. Supreme Court, demonstrating an adept handling of high-stakes IP litigation. Beyond this impressive achievement, the firm has also successfully pursued a $158 million infringement verdict for Boston Scientific.
The firm’s continued success in navigating complex IP issues has rightly earned it a place among Law360’s prestigious 2023 Intellectual Property Groups of the Year. This echelon is considered one of the highest honours within the IP legal sector, and underlines Arnold & Porter Kaye Scholer LLP’s expertise and commitment to delivering exceptional client outcomes.Details of the firm’s recognitions can be found here.
Arnold & Porter Kaye Scholer LLP’s strategic and comprehensive approach to IP law ensures its clients remain protected in the dynamic and evolving landscape of IP rights, both in the United States and globally.
However, the focus of Arnold & Porter Kaye Scholer LLP extends beyond achieving victories in court. The firm is heavily invested in the betterment of the IP legal landscape, contributing to insightful analysis and thought leadership in this niche yet critical field of law. This approach reinforces the firm’s growth strategy of securing its place as one of the leading legal institutions worldwide.
Arnold & Porter Kaye Scholer LLP symbolises a gold standard for law firms, bridging the gap between innovative ideas and the ins and outs of the judicial system, thereby bringing value to its clients and shaping the future of IP law.